Real-World Evidence

Leverage Global Expertise and Novel Methodologies to Generate High-Impact Evidence

High-Impact Real-World Evidence (RWE) for Confident Decision Making

Our scientific experts have 25 years of experience in novel methodologies and study designs, such as synthetic controls, target trial emulation, and surrogacy outcomes validation. We generate efficient, high-impact evidence that meets multiple needs, de-risking your study investments and ensuring stakeholder acceptance.

With global reach and special expertise in Europe, we help you navigate complexity with pragmatic, creative problem solving and scientifically rigorous approaches. Our unique blend of clinically rich proprietary data, advanced methodologies, and cross-functional collaboration allows us to answer your toughest RWE questions, including those in slow-progressing, multi-setting, and rare diseases.

Explore our fit-for-purpose RWE and design capabilities.

The PHARMO Institute, which is part of Lumanity, is an organization dedicated to developing cutting-edge solutions that support enhanced RWE analytics. PHARMO focuses on pharmacoepidemiology, drug utilization, drug safety, and health outcomes, with direct access to longitudinal anonymized patient-level data from the Netherlands. Together, we provide unparalleled RWE expertise and access to unique, longitudinal, and clinically rich data assets. Contact us to discuss and confirm your research insight needs.

Our Offerings

Maximize your product’s value potential with a holistic and efficient RWE plan. Understanding your product’s value story, the evidence needed to support it, and the roadmap to collecting and generating those data is key. Our RWE experts can help you:
Create your value story
Understand the evidence questions that key stakeholders will ask
Review existing data and identify gaps
Identify and access the right data
Design and conduct studies to fill evidence gaps
Communicate your complete value story to stakeholders
There is a wealth of diverse global data out there. But knowing where to go and how to acquire fit-for-purpose data can be difficult for even skilled researchers. Our Lumanity and PHARMO RWE experts have deep therapeutic area and data expertise to illuminate the right data, integrate it into a common system, and analyze it for decisive action. We can help you to:
Find and procure the right data for your needs
Connect RWE from disparate sources for interoperability
Conduct retrospective data analyses to understand the burden of disease, patient journey, treatment patterns, comparative effectiveness, and more
Demonstrating your product’s value to HTA bodies and payers requires clear and powerful evidence, generated in the most efficient way possible, to support both global needs and local implementation. We can help you with:
Post-authorization safety and efficacy studies (PASS/PAES) and drug utilization review (DUR)
Incidence/prevalence, treatment patterns, and patient pathways
Comparative effectiveness, including synthetic control arms
Healthcare resource use and cost-of-illness research
Validation of surrogacy outcomes
AI patient finding, classification, and disease-progression prediction
Maximize your product’s value potential with a holistic and efficient RWE plan. Understanding your product’s value story, the evidence needed to support it, and the roadmap to collecting and generating those data is key. Our RWE experts can help you:
Create your value story
Understand the evidence questions that key stakeholders will ask
Review existing data and identify gaps
Identify and access the right data
Design and conduct studies to fill evidence gaps
Communicate your complete value story to stakeholders
There is a wealth of diverse global data out there. But knowing where to go and how to acquire fit-for-purpose data can be difficult for even skilled researchers. Our Lumanity and PHARMO RWE experts have deep therapeutic area and data expertise to illuminate the right data, integrate it into a common system, and analyze it for decisive action. We can help you to:
Find and procure the right data for your needs
Connect RWE from disparate sources for interoperability
Conduct retrospective data analyses to understand the burden of disease, patient journey, treatment patterns, comparative effectiveness, and more
Demonstrating your product’s value to HTA bodies and payers requires clear and powerful evidence, generated in the most efficient way possible, to support both global needs and local implementation. We can help you with:
Post-authorization safety and efficacy studies (PASS/PAES) and drug utilization review (DUR)
Incidence/prevalence, treatment patterns, and patient pathways
Comparative effectiveness, including synthetic control arms
Healthcare resource use and cost-of-illness research
Validation of surrogacy outcomes
AI patient finding, classification, and disease-progression prediction

Our Impact

Proprietary Data
Our in-house PHARMO Data Network is a top 10 trusted source by the EMA and offers multi-setting, clinically rich data for EU PAS
Faster Turnaround
Study completion times of 6 to 8 months, which is significantly faster than the 12 to 18 months typical in France and the Nordics, thanks to our unique data access arrangement
Global Reach
The SIGMA Consortium, co-founded by PHARMO, provides global reach and integrated expertise from leading EU research centers
Strategic Location
A strategic location just down the road from the EMA in the Netherlands ensures seamless regulatory interactions
Our Perspectives View all perspectives
Let's Talk

We would love to hear your challenges and discuss how our team of RWE experts can help.

Dan Simpson MSc Global President, Real World Evidence
Read more about Dan Simpson
Naomi Boxall PhD, MVSc General Manager, The PHARMO Institute
Read more about Naomi Boxall
Nikita Jeswani MBA Head of Global RWE Sales
Read more about Nikita Jeswani
Josine Kuiper PhD, MSc Senior Business Development Manager, The PHARMO Institute
Read more about Josine Kuiper
Jetty Overbeek PhD, MSc Head, PHARMO Research, The PHARMO Institute
Read more about Jetty Overbeek
Meena Venkatachalam MSc Global Head, RWE Consulting
Read more about Meena Venkatachalam